Pfizer’s new RSV vaccine may trigger Guillain-Barre syndrome
positivelysharing
Reading Time: < 1minute
The Pfizer company logo displayed at Pfizer Inc. headquarters, in New York, last year.
Pfizer‘s new RSV vaccine for older adults may trigger the potentially deadly Guillain-Barre syndrome, the Food and Drug Administration (FDA) has warned. Read More
